Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?

Hyo-Cheol Kim

Clin Mol Hepatol. 2023;29(4):984-986. Published online August 14, 2023

DOI: https://doi.org/10.3350/cmh.2023.0275

View: 2305 Download: 48

Original Article

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis

Moon Haeng Hur, Yuri Cho, Do Young Kim, Jae Seung Lee, Gyoung Min Kim, Hyo-Cheol Kim, Dong Hyun Sinn, Dongho Hyun, Han Ah Lee, Yeon Seok Seo, In Joon Lee, Joong-Won Park, Yoon Jun Kim

Clin Mol Hepatol. 2023;29(3):763-778. Published online May 30, 2023

DOI: https://doi.org/10.3350/cmh.2023.0076

View: 4170 Download: 229 Web of Science: 8 Crossref: 9

Review

Radioembolization for the treatment of hepatocellular carcinoma

Hyo-Cheol Kim

Clin Mol Hepatol. 2017;23(2):109-114. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0004

View: 13234 Download: 369 Web of Science: 50 Crossref: 44

1 |

Viewed By 6394	MAFLD: How is it different from NAFLD?
Viewed By 5479	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5156	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4228	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 4014	Gut microbiome and metabolome signatures in liver cirrhosis-related complications

Cited By 272	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 230	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 156	MAFLD: How is it different from NAFLD?
Cited By 79	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 76	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search